StoneX Group’s Yarrow Bioscience YARW Stock Holding History

StoneX Group’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15	Closed	-$2.08K	–	810
2022 Q4	$2.08K	Buy	+15	New	+$3K	﹤0.01%	641

Other funds holding YARW

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

StoneX Group's YARW Position: Q1 2023 in Review

StoneX Group sold out of Yarrow Bioscience (YARW) in Q1 2023, closing a stake of 15 shares — an estimated $2.08K sold.

StoneX Group first reported a position in YARW in Q4 2022 and held it in 1 quarter. The position peaked at $2.08K in Q4 2022. 21 funds tracked by Wall St. Rank hold YARW as of Q1 2023.

StoneX Group reported no remaining Yarrow Bioscience position as of Q1 2023 after selling out during the quarter.
StoneX Group sold 15 Yarrow Bioscience shares in Q1 2023, an estimated $2.08K.
StoneX Group first reported a position in Yarrow Bioscience in Q4 2022 and held it in 1 quarter.
StoneX Group's Yarrow Bioscience position peaked at $2.08K in Q4 2022.
21 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2023.

Based on StoneX Group's 13F filing for Q1 2023, filed 11 May 2023.